Viewing Study NCT00263692


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2025-12-27 @ 12:03 PM
Study NCT ID: NCT00263692
Status: COMPLETED
Last Update Posted: 2016-09-15
First Post: 2005-12-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module